Neurobiology of Disease

Apoptosis in the in Vivo Mammalian Forebrain
pp. 359-379(21)
Authors: Dikranian K.; Ishimaru M.J.; Tenkova T.; Labruyere J.; Qin Y.Q.; Ikonomidou C.; Olney J.W.

Oxidative Cellular Damage and the Reduction of APE/Ref-1 Expression after Experimental Traumatic Brain Injury
pp. 380-390(11)
Authors: Lewén A.; Sugawara T.; Gasche Y.; Fujimura M.; Chan P.H.

Tissue Transglutaminase Selectively Modifies Proteins Associated with Truncated Mutant Huntingtin in Intact Cells
pp. 391-404(14)
Authors: Chun W.; Lesort M.; Tucholski J.; Faber P.W.; MacDonald M.E.; Ross C.A.; Johnson G.V.W.

Distinct Behavioral and Neuropathological Abnormalities in Transgenic Mouse Models of HD and DRPLA
pp. 405-418(14)
Authors: Schilling G.; Jinnah H.A.; Gonzales V.; Coonfield M.L.; Kim Y.; Wood J.D.; Price D.L.; Li X-J.; Jenkins N.; Copeland N.; Moran T.; Ross C.A.; Borchelt D.R.

A Synaptic Mechanism Underlying the Behavioral Abnormalities Induced by Manganese Intoxication
pp. 419-432(14)
Authors: Calabresi P.; Ammassari-Teule M.; Gubellini P.; Sancesario G.; Morello M.; Centonze D.; Marfia G.A.; Saulle E.; Passino E.; Picconi B.; Bernardi G.

Neuroprotective Effect of a CNTF-Expressing Lentiviral Vector in the Quinolinic Acid Rat Model of Huntington's Disease
pp. 433-446(14)
Authors: de Almeida L.P.; Zala D.; Aebischer P.; Déglon N.

The frissonnant Mutant Mouse, a Model of Dopamino-Sensitive, Inherited Motor Syndrome
pp. 447-458(12)
Authors: Callizot N.; Guénet J-L.; Baillet C.; Warter J-M.; Poindron P.

RNA Editing at the Q/R Site for the Glutamate Receptor Subunits GLUR2, GLUR5, and GLUR6 in Hippocampus and Temporal Cortex from Epileptic Patients
pp. 459-468(10)
Authors: Kortenbruck G.; Berger E.; Speckmann E.-J.; Musshoff U.

Subcellular Mechanisms of Presenilin-Mediated Enhancement of Calcium Signaling
pp. 469-478(10)
Authors: Leissring M.A.; LaFerla F.M.; Callamaras N.; Parker I.

Creatine Increases Survival and Delays Motor Symptoms in a Transgenic Animal Model of Huntington's Disease
pp. 479-491(13)
Authors: Andreassen O.A.; Dedeoglu A.; Ferrante R.J.; Jenkins B.G.; Ferrante K.L.; Thomas M.; Friedlich A.; Browne S.E.; Schilling G.; Borchelt D.R.; Hersch S.M.; Ross C.A.; Beal M.F.

Corticotropin-Releasing Hormone Protects Neurons against Insults Relevant to the Pathogenesis of Alzheimer's Disease
pp. 492-503(12)
Authors: Pedersen W.A.; McCullers D.; Culmsee C.; Haughey N.J.; Herman J.P.; Mattson M.P.

Modulation (Inhibition and Augmentation) of Complement Receptor-3-Mediated Myelin Phagocytosis
pp. 504-512(9)
Authors: Reichert F.; Slobodov U.; Makranz C.; Rotshenker S.

Differential Regulation of Transcripts for Dystrophin Isoforms, Dystroglycan, and 3AChR Subunit in Mouse Sympathetic Ganglia Following Postganglionic Nerve Crush
pp. 513-524(12)
Authors: Zaccaria M.L.; Perrone-Capano C.; Melucci-Vigo G.; Gaeta L.; Petrucci T.C.; Paggi P.

Hypocretin Levels in Sporadic and Familial Cases of Canine Narcolepsy
pp. 525-534(10)
Authors: Ripley B.; Fujiki N.; Okura M.; Mignot E.; Nishino S.

Lack of Nigral Pathology in Transgenic Mice Expressing Human -Synuclein Driven by the Tyrosine Hydroxylase Promoter
pp. 535-539(5)
Authors: Matsuoka Y.; Vila M.; Lincoln S.; McCormack A.; Picciano M.; LaFrancois J.; Yu X.; Dickson D.; Langston W.J.; McGowan E.; Farrer M.; Hardy J.; Duff K.; Przedborski S.; Di Monte D.A.

Volume 8, Number 1 (2001), in the article “Identification of Amino-Terminally and Phosphotyrosine-Modified Carboxy-Terminal Fragments of the Amyloid Precursor Protein in Alzheimer's Disease and Down's Syndrome Brain,” by Claudio Russo, Serena Salis, Virginia Dolcini, Valentina Venezia, Xiang-Hong Song, Jan K. Teller, and Gennaro Schettini, pages 173–180 (doi:10.1006/nbdi.2000.0357)
pp. 540-540(1)